Oregon Public Employees Retirement Fund’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,500
Closed -$200K 1592
2019
Q4
$200K Sell
2,500
-2,500
-50% -$187K ﹤0.01% 1466
2019
Q3
$367K Sell
5,000
-5,000
-50% -$432K ﹤0.01% 1364
2019
Q2
$943K Buy
+10,000
New +$825K 0.01% 998

Other funds holding BPMC

Oregon Public Employees Retirement Fund's BPMC Position: Q1 2020 in Review

Oregon Public Employees Retirement Fund sold out of Blueprint Medicines (BPMC) in Q1 2020, closing a stake of 2,500 shares — an estimated $200K sold.

Oregon Public Employees Retirement Fund first reported a position in BPMC in Q2 2019 and held it in 3 quarters. The position peaked at $943K in Q2 2019. 214 funds tracked by Wall St. Rank hold BPMC as of Q1 2020.

  • Oregon Public Employees Retirement Fund reported no remaining Blueprint Medicines position as of Q1 2020 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 2,500 Blueprint Medicines shares in Q1 2020, an estimated $200K.
  • Oregon Public Employees Retirement Fund first reported a position in Blueprint Medicines in Q2 2019 and held it in 3 quarters.
  • Oregon Public Employees Retirement Fund's Blueprint Medicines position peaked at $943K in Q2 2019.
  • 214 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2020.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2020, filed 20 Apr 2020.